{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:59:16Z","timestamp":1780480756443,"version":"3.54.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,5]]},"DOI":"10.7759\/cureus.83490","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T08:51:33Z","timestamp":1746435093000},"source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of Bisphosphonate and Denosumab Use in Elderly Care Facilities: Implications for the Management of Medication-Related Osteonecrosis of the Jaw"],"prefix":"10.7759","author":[{"given":"Motohiko","family":"Sano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihoko","family":"Kanbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kanbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Ariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad F","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, et al.. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol. 2012, 23:1341-7. 10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.105","article-title":"Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group","volume":"21","author":"Rosen LS","year":"2003","unstructured":"Rosen LS, Gordon D, Tchekmedyian S, et al.. Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group. J Clin Oncol. 2003, 21:3150-7. 10.1200\/JCO.2003.04.105","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.037","article-title":"American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma","volume":"20","author":"Berenson JR","year":"2002","unstructured":"Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol. 2002, 20:3719-36. 10.1200\/JCO.2002.06.037","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update","volume":"80","author":"Ruggiero SL","year":"2022","unstructured":"Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillofac Surg. 2022, 80:920-43. 10.1016\/j.joms.2022.02.008","journal-title":"J Oral Maxillofac Surg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2010.10.005","article-title":"Adverse effects of bisphosphonates","volume":"7","author":"Arboleya L","year":"2011","unstructured":"Arboleya L, Alperi M, Alonso S. Adverse effects of bisphosphonates. Reumatol Clin. 2011, 7:189-97. 10.1016\/j.reuma.2010.10.005","journal-title":"Reumatol Clin"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia A","year":"2016","unstructured":"Soundia A, Hadaya D, Esfandi N, et al.. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease. Bone. 2016, 90:133-41. 10.1016\/j.bone.2016.06.011","journal-title":"Bone"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-1819-1","article-title":"Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis","volume":"17","author":"Wehrhan F","year":"2019","unstructured":"Wehrhan F, Gross C, Creutzburg K, et al.. Osteoclastic expression of higher-level regulators NFATc1 and BCL6 in medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. J Transl Med. 2019, 17:69. 10.1186\/s12967-019-1819-1","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero SL","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014, 72:1938-56. 10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01174-2","article-title":"Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw","volume":"39","author":"Soma T","year":"2021","unstructured":"Soma T, Iwasaki R, Sato Y, et al.. Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. J Bone Miner Metab. 2021, 39:372-84. 10.1007\/s00774-020-01174-2","journal-title":"J Bone Miner Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen T","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, James Kirkpatrick C. Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med. 2006, 35:155-60. 10.1111\/j.1600-0714.2006.00391.x","journal-title":"J Oral Pathol Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0022034511420430","article-title":"A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw","volume":"90","author":"Mawardi H","year":"2011","unstructured":"Mawardi H, Giro G, Kajiya M, et al.. A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw. J Dent Res. 2011, 90:1339-45. 10.1177\/0022034511420430","journal-title":"J Dent Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr039","article-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience","volume":"23","author":"Vandone AM","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M, et al.. Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol. 2012, 23:193-200. 10.1093\/annonc\/mdr039","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcms.2016.07.026","article-title":"Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - a prospective study over 6 years","volume":"44","author":"M\u00fccke T","year":"2016","unstructured":"M\u00fccke T, Deppe H, Hein J, et al.. Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - a prospective study over 6 years. J Craniomaxillofac Surg. 2016, 44:1689-93. 10.1016\/j.jcms.2016.07.026","journal-title":"J Craniomaxillofac Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4140\/TCP.n.2022.458","article-title":"A dentist\u2019s perspective on the need for interdisciplinary collaboration to reduce medication-related osteonecrosis of the jaw","volume":"37","author":"Griffin A","year":"2022","unstructured":"Griffin A, Brain P, Hancock C, Jeyapalina S. A dentist\u2019s perspective on the need for interdisciplinary collaboration to reduce medication-related osteonecrosis of the jaw. Sr Care Pharm. 2022, 37:458-67. 10.4140\/TCP.n.2022.458","journal-title":"Sr Care Pharm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0183","article-title":"Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw","volume":"16","author":"Miksad RA","year":"2011","unstructured":"Miksad RA, Lai KC, Dodson TB, et al.. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011, 16:121-32. 10.1634\/theoncologist.2010-0183","journal-title":"Oncologist"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024376","article-title":"Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England","volume":"9","author":"Sturrock A","year":"2019","unstructured":"Sturrock A, Preshaw PM, Hayes C, Wilkes S. Perceptions and attitudes of patients towards medication-related osteonecrosis of the jaw (MRONJ): a qualitative study in England. BMJ Open. 2019, 9:e024376. 10.1136\/bmjopen-2018-024376","journal-title":"BMJ Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/10781552251316440","article-title":"Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: single-center retrospective study [PREPRINT]","author":"Sano M","year":"2025","unstructured":"Sano M, Amano M, Yamada M, et al.. Medication-related osteonecrosis of the jaw in patients with cancer using zoledronic acid and denosumab: single-center retrospective study [PREPRINT]. J Oncol Pharm Pract. 2025, 10.1177\/10781552251316440","journal-title":"J Oncol Pharm Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/23337214241292794","article-title":"Dental Hygienists\u2019 awareness of medication-related osteonecrosis of the jaw in private dental clinics in Japan","volume":"10","author":"Iijima Y","year":"2024","unstructured":"Iijima Y, Yamada M, Amano M, et al.. Dental Hygienists\u2019 awareness of medication-related osteonecrosis of the jaw in private dental clinics in Japan. Gerontol Geriatr Med. 2024, 10:23337214241292794. 10.1177\/23337214241292794","journal-title":"Gerontol Geriatr Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235526","article-title":"Comparative risk of bleeding of anticoagulant therapy with vitamin K antagonists (VKAs) and with non-vitamin K antagonists in patients undergoing dental surgery","volume":"10","author":"Manfredini M","year":"2021","unstructured":"Manfredini M, Poli PP, Creminelli L, Porro A, Maiorana C, Beretta M. Comparative risk of bleeding of anticoagulant therapy with vitamin K antagonists (VKAs) and with non-vitamin K antagonists in patients undergoing dental surgery. J Clin Med. 2021, 10:5526. 10.3390\/jcm10235526","journal-title":"J Clin Med"},{"key":"ref20","article-title":"Management of the hypertensive dental patient","volume":"89","author":"Valtellini R","year":"2023","unstructured":"Valtellini R, Ouanounou A. Management of the hypertensive dental patient. J Can Dent Assoc. 2023, 89:2.","journal-title":"J Can Dent Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-022-01352-4","article-title":"Trends in osteoporosis prevalence over a 10-year period in Japan: the ROAD study 2005-2015","volume":"40","author":"Yoshimura N","year":"2022","unstructured":"Yoshimura N, Iidaka T, Horii C, et al.. Trends in osteoporosis prevalence over a 10-year period in Japan: the ROAD study 2005-2015. J Bone Miner Metab. 2022, 40:829-38. 10.1007\/s00774-022-01352-4","journal-title":"J Bone Miner Metab"},{"key":"ref22","article-title":"Epidemiology of osteoporosis in Japan (Article in Japanese)","volume":"22","author":"Iki M","year":"2012","unstructured":"Iki M. Epidemiology of osteoporosis in Japan (Article in Japanese). Clin Calcium. 2012, 22:797-803.","journal-title":"Clin Calcium"},{"key":"ref23","article-title":"Epidemiology of osteoporosis: incidence, prevalence, and prognosis (Article in Japanese)","volume":"56","author":"Suzuki T","year":"1998","unstructured":"Suzuki T, Yoshida H, Ishizaki T. Epidemiology of osteoporosis: incidence, prevalence, and prognosis (Article in Japanese). Nihon Rinsho. 1998, 56:1563-8.","journal-title":"Nihon Rinsho"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1474-9","article-title":"A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis","volume":"4","author":"Horikawa A","year":"2015","unstructured":"Horikawa A, Miyakoshi N, Shimada Y, Sugimura Y, Kodama H. A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis. Springerplus. 2015, 4:675. 10.1186\/s40064-015-1474-9","journal-title":"Springerplus"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2013.130017","article-title":"Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw","volume":"85","author":"Thumbigere-Math V","year":"2014","unstructured":"Thumbigere-Math V, Michalowicz BS, Hodges JS, Tsai ML, Swenson KK, Rockwell L, Gopalakrishnan R. Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol. 2014, 85:226-33. 10.1902\/jop.2013.130017","journal-title":"J Periodontol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.oooo.2018.08.015","article-title":"Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study","volume":"126","author":"Hallmer F","year":"2018","unstructured":"Hallmer F, Andersson G, G\u00f6trick B, Warfvinge G, Anderud J, Bj\u00f8rnland T. Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018, 126:477-85. 10.1016\/j.oooo.2018.08.015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study","volume":"41","author":"Yamazaki T","year":"2012","unstructured":"Yamazaki T, Yamori M, Ishizaki T, et al.. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg. 2012, 41:1397-403. 10.1016\/j.ijom.2012.06.020","journal-title":"Int J Oral Maxillofac Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis A","year":"2008","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G, et al.. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. 2008, 26:4634-8. 10.1200\/JCO.2008.16.2768","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H521","article-title":"Bisphosphonate-induced osteonecrosis of the jaw","volume":"41","author":"Krueger CD","year":"2007","unstructured":"Krueger CD, West PM, Sargent M, Lodolce AE, Pickard AS. Bisphosphonate-induced osteonecrosis of the jaw. Ann Pharmacother. 2007, 41:276-84. 10.1345\/aph.1H521","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/355738-prevalence-of-bisphosphonate-and-denosumab-use-in-elderly-care-facilities-implications-for-the-management-of-medication-related-osteonecrosis-of-the-jaw","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T08:51:34Z","timestamp":1746435094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/355738-prevalence-of-bisphosphonate-and-denosumab-use-in-elderly-care-facilities-implications-for-the-management-of-medication-related-osteonecrosis-of-the-jaw"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.83490","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}